E. Wood

发表

TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

Murray Grossman, James B Leverenz, Maria Martinez-Lage, 2008, The Lancet Neurology.

A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitro

G. Schellenberg, B. Miller, J. Trojanowski, 2008, FEBS letters.

TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Murray Grossman, Peachie Moore, John Q Trojanowski, 2007, Archives of neurology.

CSF biomarkers in frontotemporal lobar degeneration with known pathology

J. Trojanowski, M. Grossman, C. Clark, 2008, Neurology.

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations

J. Trojanowski, M. Grossman, C. Clark, 2008, Neurology.

The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

G. Schellenberg, T. Montine, J. Trojanowski, 2010, Archives of neurology.

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative

D. Geschwind, G. Schellenberg, B. Miller, 2007, The Lancet Neurology.

Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

Murray Grossman, John L. Robinson, J. Trojanowski, 2013, Annals of neurology.

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis

Jonathan M. Bekisz, J. Trojanowski, L. Shaw, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Kevin F. Bieniek, D. Geschwind, M. Mesulam, 2013, Neurology.

A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

Deepak L. Bhatt, R. Green, C. Royal, 2015, Alzheimer's & Dementia.

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials

P. Tariot, J. Karlawish, E. Reiman, 2019, Alzheimer's & dementia.

Brain progranulin expression in GRN-associated frontotemporal lobar degeneration

J. Trojanowski, M. Grossman, V. Lee, 2009, Acta Neuropathologica.

Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.

M. Grossman, D. Irwin, S. Xie, 2013, JAMA neurology.

Comparison of family histories in FTLD subtypes and related tauopathies

J. Neuhaus, M. Grossman, V. Lee, 2005, Neurology.

Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration

Brian B. Avants, Philip A. Cook, Murray Grossman, 2014, Neurobiology of Aging.

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

Murray Grossman, Leslie M. Shaw, John Q. Trojanowski, 2014, Alzheimer's & Dementia.

Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.

Jennifer Farmer, Murray Grossman, Anjan Chatterjee, 2007, Archives of neurology.

Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration

J. Trojanowski, M. Grossman, J. Toledo, 2015, Acta Neuropathologica.

Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier

M. Grossman, N. Cairns, C. McMillan, 2014, Acta Neuropathologica.

Evaluation of an educational conference for persons affected by hereditary frontotemporal degeneration and amyotrophic lateral sclerosis

M. Grossman, D. Irwin, T. Bardakjian, 2022, PEC innovation.

ALS-Plus syndrome: Non-pyramidal features in a large ALS cohort

John Powers, A. Boller, K. Rascovsky, 2014, Journal of the Neurological Sciences.

Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia

J. Trojanowski, M. Grossman, V. Lee, 2014, Neurology.

GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies

P. Tariot, J. Karlawish, E. Reiman, 2019, Alzheimer's & Dementia.

Prenatal healthcare providers’ Gaucher disease carrier screening practices

S. Xie, V. Deerlin, E. Wood, 2012, Genetics in Medicine.

Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.

J. Trojanowski, M. Grossman, C. Clark, 2007, Archives of neurology.

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.

William T. Hu, G. Schellenberg, J. Grafman, 2011, Archives of neurology.